Industry: Pharma & Healthcare
Published Date: 2025-01-01
Pages: 88 Pages
Report ld: 3453634
Request Sample
Customized Report
The global market for Adjunctive Hemostats was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Adjunctive Hemostats, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adjunctive Hemostats.
The Adjunctive Hemostats market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adjunctive Hemostats market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adjunctive Hemostats manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Segment by Type
Gauze
Powder
Gelatin Sponge
Other
Segment by Application
Hospital
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Adjunctive Hemostats manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Adjunctive Hemostats in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Adjunctive Hemostats Market Overview
1.1 Product Definition
1.2 Adjunctive Hemostats by Type
1.2.1 Global Adjunctive Hemostats Market Value Comparison by Type (2024 VS 2031)
1.2.2 Gauze
1.2.3 Powder
1.2.4 Gelatin Sponge
1.2.5 Other
1.3 Adjunctive Hemostats by Application
1.3.1 Global Adjunctive Hemostats Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Global Adjunctive Hemostats Market Size Estimates and Forecasts
1.4.1 Global Adjunctive Hemostats Revenue 2020-2031
1.4.2 Global Adjunctive Hemostats Sales 2020-2031
1.4.3 Global Adjunctive Hemostats Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Adjunctive Hemostats Market Competition by Manufacturers
2.1 Global Adjunctive Hemostats Sales Market Share by Manufacturers (2020-2025)
2.2 Global Adjunctive Hemostats Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Adjunctive Hemostats Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Adjunctive Hemostats, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Adjunctive Hemostats, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Adjunctive Hemostats, Product Type & Application
2.7 Global Key Manufacturers of Adjunctive Hemostats, Date of Enter into This Industry
2.8 Global Adjunctive Hemostats Market Competitive Situation and Trends
2.8.1 Global Adjunctive Hemostats Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Adjunctive Hemostats Players Market Share by Revenue
2.8.3 Global Adjunctive Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Adjunctive Hemostats Market Scenario by Region
3.1 Global Adjunctive Hemostats Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Adjunctive Hemostats Sales by Region: 2020-2031
3.2.1 Global Adjunctive Hemostats Sales by Region: 2020-2025
3.2.2 Global Adjunctive Hemostats Sales by Region: 2026-2031
3.3 Global Adjunctive Hemostats Revenue by Region: 2020-2031
3.3.1 Global Adjunctive Hemostats Revenue by Region: 2020-2025
3.3.2 Global Adjunctive Hemostats Revenue by Region: 2026-2031
3.4 North America Adjunctive Hemostats Market Facts & Figures by Country
3.4.1 North America Adjunctive Hemostats Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Adjunctive Hemostats Sales by Country (2020-2031)
3.4.3 North America Adjunctive Hemostats Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Adjunctive Hemostats Market Facts & Figures by Country
3.5.1 Europe Adjunctive Hemostats Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Adjunctive Hemostats Sales by Country (2020-2031)
3.5.3 Europe Adjunctive Hemostats Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adjunctive Hemostats Market Facts & Figures by Region
3.6.1 Asia Pacific Adjunctive Hemostats Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Adjunctive Hemostats Sales by Region (2020-2031)
3.6.3 Asia Pacific Adjunctive Hemostats Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Adjunctive Hemostats Market Facts & Figures by Country
3.7.1 Latin America Adjunctive Hemostats Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Adjunctive Hemostats Sales by Country (2020-2031)
3.7.3 Latin America Adjunctive Hemostats Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Adjunctive Hemostats Market Facts & Figures by Country
3.8.1 Middle East and Africa Adjunctive Hemostats Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Adjunctive Hemostats Sales by Country (2020-2031)
3.8.3 Middle East and Africa Adjunctive Hemostats Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Adjunctive Hemostats Sales by Type (2020-2031)
4.1.1 Global Adjunctive Hemostats Sales by Type (2020-2025)
4.1.2 Global Adjunctive Hemostats Sales by Type (2026-2031)
4.1.3 Global Adjunctive Hemostats Sales Market Share by Type (2020-2031)
4.2 Global Adjunctive Hemostats Revenue by Type (2020-2031)
4.2.1 Global Adjunctive Hemostats Revenue by Type (2020-2025)
4.2.2 Global Adjunctive Hemostats Revenue by Type (2026-2031)
4.2.3 Global Adjunctive Hemostats Revenue Market Share by Type (2020-2031)
4.3 Global Adjunctive Hemostats Price by Type (2020-2031)
5 Segment by Application
5.1 Global Adjunctive Hemostats Sales by Application (2020-2031)
5.1.1 Global Adjunctive Hemostats Sales by Application (2020-2025)
5.1.2 Global Adjunctive Hemostats Sales by Application (2026-2031)
5.1.3 Global Adjunctive Hemostats Sales Market Share by Application (2020-2031)
5.2 Global Adjunctive Hemostats Revenue by Application (2020-2031)
5.2.1 Global Adjunctive Hemostats Revenue by Application (2020-2025)
5.2.2 Global Adjunctive Hemostats Revenue by Application (2026-2031)
5.2.3 Global Adjunctive Hemostats Revenue Market Share by Application (2020-2031)
5.3 Global Adjunctive Hemostats Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Adjunctive Hemostats Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 BD
6.2.1 BD Company Information
6.2.2 BD Description and Business Overview
6.2.3 BD Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BD Adjunctive Hemostats Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Baxter
6.3.1 Baxter Company Information
6.3.2 Baxter Description and Business Overview
6.3.3 Baxter Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Baxter Adjunctive Hemostats Product Portfolio
6.3.5 Baxter Recent Developments/Updates
6.4 B.Braun
6.4.1 B.Braun Company Information
6.4.2 B.Braun Description and Business Overview
6.4.3 B.Braun Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.4.4 B.Braun Adjunctive Hemostats Product Portfolio
6.4.5 B.Braun Recent Developments/Updates
6.5 Cura Medical
6.5.1 Cura Medical Company Information
6.5.2 Cura Medical Description and Business Overview
6.5.3 Cura Medical Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cura Medical Adjunctive Hemostats Product Portfolio
6.5.5 Cura Medical Recent Developments/Updates
6.6 GELITA MEDICAL
6.6.1 GELITA MEDICAL Company Information
6.6.2 GELITA MEDICAL Description and Business Overview
6.6.3 GELITA MEDICAL Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GELITA MEDICAL Adjunctive Hemostats Product Portfolio
6.6.5 GELITA MEDICAL Recent Developments/Updates
6.7 Curasan AG
6.7.1 Curasan AG Company Information
6.7.2 Curasan AG Description and Business Overview
6.7.3 Curasan AG Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Curasan AG Adjunctive Hemostats Product Portfolio
6.7.5 Curasan AG Recent Developments/Updates
6.8 Meril Life Sciences
6.8.1 Meril Life Sciences Company Information
6.8.2 Meril Life Sciences Description and Business Overview
6.8.3 Meril Life Sciences Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Meril Life Sciences Adjunctive Hemostats Product Portfolio
6.8.5 Meril Life Sciences Recent Developments/Updates
6.9 Zhonghui Shengxi
6.9.1 Zhonghui Shengxi Company Information
6.9.2 Zhonghui Shengxi Description and Business Overview
6.9.3 Zhonghui Shengxi Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zhonghui Shengxi Adjunctive Hemostats Product Portfolio
6.9.5 Zhonghui Shengxi Recent Developments/Updates
6.10 Beijing Datsing Bio-tech
6.10.1 Beijing Datsing Bio-tech Company Information
6.10.2 Beijing Datsing Bio-tech Description and Business Overview
6.10.3 Beijing Datsing Bio-tech Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Beijing Datsing Bio-tech Adjunctive Hemostats Product Portfolio
6.10.5 Beijing Datsing Bio-tech Recent Developments/Updates
6.11 Guizhou Jin Jiu Biotech
6.11.1 Guizhou Jin Jiu Biotech Company Information
6.11.2 Guizhou Jin Jiu Biotech Description and Business Overview
6.11.3 Guizhou Jin Jiu Biotech Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Guizhou Jin Jiu Biotech Adjunctive Hemostats Product Portfolio
6.11.5 Guizhou Jin Jiu Biotech Recent Developments/Updates
6.12 Beijing Taikesiman
6.12.1 Beijing Taikesiman Company Information
6.12.2 Beijing Taikesiman Description and Business Overview
6.12.3 Beijing Taikesiman Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Beijing Taikesiman Adjunctive Hemostats Product Portfolio
6.12.5 Beijing Taikesiman Recent Developments/Updates
6.13 Foryou Medical
6.13.1 Foryou Medical Company Information
6.13.2 Foryou Medical Description and Business Overview
6.13.3 Foryou Medical Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Foryou Medical Adjunctive Hemostats Product Portfolio
6.13.5 Foryou Medical Recent Developments/Updates
6.14 Saikesaisi Holdings Group
6.14.1 Saikesaisi Holdings Group Company Information
6.14.2 Saikesaisi Holdings Group Description and Business Overview
6.14.3 Saikesaisi Holdings Group Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Saikesaisi Holdings Group Adjunctive Hemostats Product Portfolio
6.14.5 Saikesaisi Holdings Group Recent Developments/Updates
6.15 Biotemed
6.15.1 Biotemed Company Information
6.15.2 Biotemed Description and Business Overview
6.15.3 Biotemed Adjunctive Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Biotemed Adjunctive Hemostats Product Portfolio
6.15.5 Biotemed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adjunctive Hemostats Industry Chain Analysis
7.2 Adjunctive Hemostats Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adjunctive Hemostats Production Mode & Process Analysis
7.4 Adjunctive Hemostats Sales and Marketing
7.4.1 Adjunctive Hemostats Sales Channels
7.4.2 Adjunctive Hemostats Distributors
7.5 Adjunctive Hemostats Customer Analysis
8 Adjunctive Hemostats Market Dynamics
8.1 Adjunctive Hemostats Industry Trends
8.2 Adjunctive Hemostats Market Drivers
8.3 Adjunctive Hemostats Market Challenges
8.4 Adjunctive Hemostats Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Adjunctive Hemostats market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-12
Pages: 118
USD 4900.00
(Single User License)
The global Adjunctive Hemostats market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 105
USD 2900.00
(Single User License)
The global market for Adjunctive Hemostats was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-10
Pages: 141
USD 3950.00
(Single User License)
The global Adjunctive Hemostats market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-12
Pages: 118
The global Adjunctive Hemostats market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 105
The global market for Adjunctive Hemostats was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-10
Pages: 141
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now